DCVAC/LuCa

DCVAC/LuCa · SOTIO a.s.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DCVAC/LuCa, covering 2022-05-04 to 2022-05-04. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer [Phase 1, Phase 2]

See pricing